Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)

By Ley Ludwin   Schumacher Helmut  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 41-53

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy

By Schunkert H   Glazer R.D.   Wernsing M.   Yen J.   Macarie C.E.   Vintila M.M.   Romanova J  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2655-2662

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (±amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg

By Schweizer Johannes   Ulmer Hans-Joachim   Benduhn Henning   Klebs Sven  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 131-140

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on valsartan monotherapy

By Sinkiewicz W.   Glazer R. D.   Kavoliuniene A.   Miglinas M.   Prak H.   Wernsing M.   Yen J.  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite